Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Dupilumab users have a higher risk of developing alopecia areata.

Most children with alopecia areata have patchy hair loss and common trichoscopic features like yellow and black dots.

The Fas/FasL pathway may play a role in alopecia areata.

ChatGPT 4.0 and Gemini 1.5 Flash are effective for educating patients about androgenetic alopecia, while Deepseek R1 is less reliable.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Two different mutations in the vitamin D receptor gene cause different symptoms and responses to treatment in Lebanese patients with hereditary rickets.

The SAAD-41 is a valid tool for assessing distress in people with Alopecia Areata.

Unmarried individuals and those with diabetes have a poorer quality of life with alopecia areata.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

A 36-year-old person with a female appearance but male chromosomes was diagnosed with a rare enzyme deficiency affecting sexual development.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Alopecia areata significantly impacts patients' mental health and quality of life.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

The ethanol patch test reliably identifies ALDH phenotype.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Alopecia linked to higher anxiety and personality disorders.

A reliable method was developed to measure aristolochic acid-I in rat blood.

A 12-year-old boy with PAIS successfully developed male characteristics using high-dose testosterone and anastrozole.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Vitamin B12, folate, ferritin, and iron levels are not linked to alopecia areata.

A new method can better diagnose eruptive vellus hair cysts.

Minoxidil is less effective on eyebrows and eyelashes than scalp hair because these areas have lower enzyme activity needed to activate the drug.

Using hair gel is an effective and patient-friendly way to keep hair out of the way during ear surgery.